Potential US pharma import tariffs could raise prices, stifle innovation, and revolutionise how the industry produces drugs.

The county joins municipalities across the country suing Eli Lilly, CVS Caremark, and others for sky-high prices.

US drug prices are up to five times higher than in other developed nations. Trump's order requires US drug prices to align ...

Analysts are still crunching the numbers on the impact of President Donald Trump's executive order from Monday on drug pricing. HSBC analyst Rajesh Kumar says a 20% price cut in government channels ...

The obesity drug helped people trim about two inches more off their waists than Wegovy in the first head-to-head study of the ...

Announcement pressures pharma stocks on worries profits will be hit if they have to cut prices in US. Read more at ...

Shares of pharmaceutical companies fell across the world after US President Donald Trump said he planned to order a cut in US ...

Shares of Alphamab Oncology plunged 14.4% to HK$6.28, leading declines in Hong Kong-listed pharmaceutical stocks.Meanwhile, ...

Now, this won't come as too much of a surprise to Eli Lilly and its peers. A few weeks ago, the company's CEO, David Ricks, predicted that though Trump had spared the industry with tariffs ...

Eli Lilly is proving that being second but better ... Both firms face trouble ahead. Donald Trump’s tariffs, though on hold for now, could hurt. Neither makes its entire American supply locally.

Although AbbVie, Eli Lilly ... impact. Michaels noted "penalties in the government channel and with existing contracts in the commercial setting" as barriers to hiking drug prices. However, the ...

Founded in 1993, The Motley Fool is a financial services company dedicated to making the world smarter, happier, and richer. The Motley Fool reaches millions of people every month through our premium ...